MERCK & CO | 35,438 Euro | -0,590 -1,64 % | |
| WKN: A0YD8Q ISIN: US58933Y1055 Ticker-Symbol: 6MK | Frankfurt | 17.05.13 | 17:25 Uhr |
Branche PharmaAktienmarkt DJ IndustrialS&P 100 S&P 500 |
|
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 17.05. | Bristol-Myers, Merck And Roche: R&D Finds Golden Pill, So Buy | 26 | Seeking Alpha | |
| 17.05. | Judge refuses to approve Vioxx settlement | 2 | The Age | |
| 16.05. | Merck prices $6.5 billion debt offering | 1 | bizjournals | |
| 16.05. | Merck Prices $6.5 Bln Debt Offering | 131 | AFX News | |
| WHITEHOUSE STATION (dpa-AFX) - Drugmaker Merck & Co., Inc. (MRK) said
Wednesday that it has priced a $6.5 billion public offering of senior unsecured
notes, consisting of $1.0 billion of... Mehr lesen zu: Merck Prices $6.5 Bln Debt Offering | ||||
| 15.05. | AmEx, Merck Lead $16.2 Billion of Company Bond Offerings in U.S. | 1 | Bloomberg | |
| 15.05. | Merck Plans $6.5 Billion Bond Offering for Stock Repurchases | 3 | Bloomberg | |
| 15.05. | 2 Red Flags for Merck's Type 2 Diabetes Blockbuster | 4 | Motley Fool | |
| 15.05. | Quintiles and Merck shake hands on five-year deal | 4 | bizjournals | |
| 15.05. | FDA Accepts Merck BLA | 5 | Zacks | |
| 15.05. | Moody's lowers Merck's long-term debt rating | 2 | Yahoo-USA | |
| 15.05. | Can Merck's Pipeline Offset The Pain From Major Patent Expirations? | 3 | Seeking Alpha | |
| 14.05. | Merck's Management Discusses Q1 2013 Results - Earnings Call Transcript | 3 | Seeking Alpha | |
| 14.05. | Higher prices for MS drug help drug firm Merck | 3 | Yahoo-USA | |
| 11.05. | Merck Stock: Not a Safe Pick for Dividend Investors | 14 | Motley Fool | |
| 10.05. | Merck hit with $100 million discrimination suit | 5 | bizjournals | |
| 10.05. | The FDA Approval Of Merck's Cholesterol Lowerer, Liptruzet, Doesn't Help Its Credibility | 2 | Forbes | |
| 10.05. | FDA accepts Merck biologics license application for allergy immunotherapy tablet | 2 | Pharma Bus Review | |
| 09.05. | FDA accepts Merck's allergy drug for review | 2 | bizjournals | |
| 09.05. | Merck Breaks Through Resistance at $45.42 | 5 | SmarTrend | |
| 09.05. | Merck sales rep files lawsuit saying company discriminates against women and pregnant women | 4 | Yahoo-CAN | |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| PFIZER | 22,565 | -1,03 % | Global Vision Selected by Pfizer for Worldwide Deployment of Automated Proofreading Solutions |
| NOVARTIS | 57,46 | -1,61 % | Gericht prüft Klage von Pharmakonzern Novartis gegen Bewertung |
| MERCK KGAA | 119,00 | -0,08 % | Die Woche der Entscheidung – Commerzbank, K+S, RWE, ThyssenKrupp, Merck und die Deutsche Post im Fokus |
| SANOFI | 84,54 | -0,06 % | Berenberg hebt Ziel für Sanofi auf 93 Euro - 'Hold' |
| GLAXOSMITHKLINE | 20,26 | -0,34 % | Berenberg hebt Ziel für GlaxoSmithKline auf 1.870 Pence - 'Buy' |
